Close Menu

Meridian Bioscience

Bio-Rad has launched PrimePCR assays for Droplet Digital PCR.

Meridian Bioscience said this week that it has received US Food and Drug Administration clearance for Illumigene Mycoplasma, a molecular diagnostic test for Mycoplasma pneumoniae.

NEW YORK (GenomeWeb News) – Meridian Bioscience today announced the US Food and Drug Administration cleared its molecular diagnostic test for Mycoplasma pneumonia.

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported essentially flat year-over-year sales growth for the second quarter, though adoption of its molecular diagnostic platform continued to accelerate.

Meridian Bioscience said this week that the US Food and Drug Administration has re-categorized its Illumigene Group A Streptococcus and Group B Streptococcus tests as moderate complexity under the Clinical Laboratory Improvement Amendments.

NEW YORK (GenomeWeb News) – Meridian Bioscience said on Monday that its illumigene Group A Streptococcus and illumigene Group B Streptococcus assays have been recategorized by the US Food and Drug Administration as "moderate complexity" tests under the Clinical Laboratory Improv

Cepheid's Xpert CT/NG assay for detecting Chlamydia trahcomatis and Neisseria gonorrhoeae is at least as accurate as two other commercially available molecular tests for the bacteria, according to the recently published results of the beta phase of a multi-center clinical

Meridian Bioscience's Illumigene nucleic acid amplification test for Streptococcus pyogenes, or Group A Streptococcus, has a clinical sensitivity of 99 percent and specificity of 99.6 percent when compared to the diagnostic gold standard of culture and discrepan

Bioline, a subsidiary of Meridian Bioscience, this week launched its Isolate II range of nucleic acid purification kits.

Meridian Bioscience said today that its Illumigene molecular diagnostic products accounted for 16 percent of its fiscal first quarter revenues, which increased 13 percent over the same quarter last year.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.